Editorial: Pharmacokinetic-pharmacodynamic model of drugs and their pharmacokinetic differences between normal and disease states.
作者信息
Gong Zipeng, Chen Ruixing, Ye Ling, Ma Guo, Xian Yanfang, Kulkarni Kaustubh
机构信息
State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Provincial Key Laboratory of Pharmaceutics, School of Pharmacy, Guizhou Medical University, Guiyang, China.
Key Laboratory of Basic Pharmacology of Ministry of Education, Zunyi Medical University, Zunyi, China.
出版信息
Front Pharmacol. 2024 Aug 5;15:1451176. doi: 10.3389/fphar.2024.1451176. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Pharmacokinetic-pharmacodynamic model of drugs and their pharmacokinetic differences between normal and disease states.社论：药物的药代动力学-药效学模型及其在正常和疾病状态下的药代动力学差异
Front Pharmacol. 2024 Aug 5;15:1451176. doi: 10.3389/fphar.2024.1451176. eCollection 2024.
2
Editorial: Pharmacokinetic differences of drugs and their regulatory mechanisms under dual status including normal and diseased organism.社论：药物在正常和患病机体双重状态下的药代动力学差异及其调控机制
Front Pharmacol. 2022 Dec 12;13:1063434. doi: 10.3389/fphar.2022.1063434. eCollection 2022.
3
Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy.药物代谢酶和转运体的药物基因组学：对癌症治疗的影响。
Pharmgenomics Pers Med. 2011;4:11-33. doi: 10.2147/PGPM.S18861. Epub 2011 Apr 1.
4
Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.种族差异再探讨：给药方案和剂型对药代动力学和药效学的影响
Clin Pharmacokinet. 2006;45(10):957-64. doi: 10.2165/00003088-200645100-00001.
5
Drug-drug Interactions of Angiotensin Converting Enzyme Inhibitors Mediated by Metabolizing Enzymes and Transporters.由代谢酶和转运体介导的血管紧张素转换酶抑制剂的药物相互作用
Curr Drug Metab. 2018;19(13):1119-1129. doi: 10.2174/1389200219666180730163953.
6
Role of membrane transporters and metabolizing enzymes in ocular drug delivery.膜转运体和代谢酶在眼部药物递送中的作用。
Curr Drug Metab. 2014;15(7):680-93. doi: 10.2174/1389200215666140926152459.
7
Pharmacokinetic-pharmacodynamic modeling of rocuronium in case of a decreased number of acetylcholine receptors: a study in myasthenic pigs.乙酰胆碱受体数量减少时罗库溴铵的药代动力学-药效学建模：对重症肌无力猪的研究
Anesthesiology. 2003 Jan;98(1):133-42. doi: 10.1097/00000542-200301000-00022.
8
Pharmacogenomics of drug-metabolizing enzymes and drug transporters in chemotherapy.化疗中药物代谢酶和药物转运体的药物基因组学
Methods Mol Biol. 2008;448:63-76. doi: 10.1007/978-1-59745-205-2_5.
9
Food Bioactive Compounds and Their Interference in Drug Pharmacokinetic/Pharmacodynamic Profiles.食品生物活性化合物及其对药物药代动力学/药效学特征的干扰。
Pharmaceutics. 2018 Dec 14;10(4):277. doi: 10.3390/pharmaceutics10040277.
本文引用的文献
1
Analyzing the Material Basis of Anti-RSV Efficacy of Lonicerae japonicae Flos Based on the PK-PD Model.基于PK-PD模型分析金银花抗呼吸道合胞病毒药效的物质基础
Molecules. 2023 Sep 5;28(18):6437. doi: 10.3390/molecules28186437.
2
Pharmacokinetic Differences of Wuji Pill Components in Normal and Chronic Visceral Hypersensitivity Irritable Bowel Syndrome Rats Attributable to Changes in Tight Junction and Transporters.基于紧密连接和转运体变化探讨戊己丸成分在正常及慢性内脏高敏感性肠易激综合征大鼠中的药代动力学差异
Front Pharmacol. 2022 Jul 8;13:948678. doi: 10.3389/fphar.2022.948678. eCollection 2022.
3
[Advances on pharmacokinetics of traditional Chinese medicine under disease states].[疾病状态下中药药代动力学研究进展]
Zhongguo Zhong Yao Za Zhi. 2015 Jan;40(2):169-73.
4
Pharmacokinetic/pharmacodynamic modeling in drug research and development.药物研发中的药代动力学/药效学建模
J Clin Pharmacol. 2000 Dec;40(12 Pt 2):1399-418.
Zotero 插件